In partnership with the National Kidney Foundation, Telligen is excited to offer the

Chronic Kidney Disease ECHO® Series

Kicks off Tuesday, April 25, 2023 at 12-1 p.m. CST

Sessions will take place every other Tuesday at 12-1 p.m. CST or

Thursday at 1-2 p.m. CST

Curriculum topics will include:

  • Screening and diagnosis of chronic kidney disease (CKD), overview of diagnosis, disparities at local level
  • SGLT2 inhibitors and GLP-1 agonists in CKD and diabetes
  • Hypertension screening and management and its relationship to CKD
  • Diabetes management: education and support
  • When and how: referral to nephrology and how to co-manage patients
  • Insulin management in patients with CKD and diabetes
  • Management of CKD complications and dialysis patients
  • Lifestyle management in chronic disease
  • Patient activation and health literacy

Target audience:

Primary care providers as well as any healthcare professionals involved in the care of patients living with chronic disease


Panel of experts will include:

  • Nephrologists
  • Primary care providers
  • Nephrology pharmacy specialist
  • Registered dietitian
  • Social worker
  • Patients with CKD

Free and accredited:

The entire healthcare team can obtain free 1.0 CME/CEUs per session for participating.

Easy to participate:

All you need is internet access, a camera and audio. 

Submit Interest Form Here

The ECHO® Model is an “all teach, all learn” approach to disseminate and implement best practices across diverse disciplines.

This series will be a 60-minute case-based learning series with the goal of increasing clinicians’ confidence levels in early testing, diagnosis, management and patient support. 

This material was prepared by Telligen, a Quality Innovation Network-Quality Improvement Organization, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this material do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. This material is for informational purposes only and does not constitute medical advice; it is not intended to be a substitute for professional medical advice, diagnosis or treatment.12SOW-QIN-03/08/23-4736


Contact Whitney Watts ( or Michael Boyson (